过敏性鼻炎对未来教育成绩的影响:一项丹麦现实世界注册研究
Signe Voss Vahlkvist1, Mercedes Romano Rodriguez2, Mikkel Pedersen3
1Department of Pediatrics and Adolescent Medicine, Lillebaelt Hospital, University Hospital of Southern Denmark, Kolding, Denmark.
Current medical research and opinion
|January 14, 2025
概括
过敏性鼻炎 (AR) 没有影响丹麦儿童的教育成果. 然而,使用AR缓解药物与提高学业表现有关,这表明治疗的好处超出了缓解症状.
科学领域:
- 医学研究 医学研究
- 公共卫生 公共卫生
- 儿科 儿科 儿科
背景情况:
- 过敏性鼻炎 (AR) 严重负担个人,影响日常生活.
- 关于AR对教育和药物效应的影响,现实世界的数据有限.
研究的目的:
- 研究过敏性鼻炎 (AR) 对教育成果的影响.
- 评估AR缓解药物对学业成绩的影响.
主要方法:
- 丹麦一项基于登记的研究包括了在13岁之前被诊断患有AR的个人.
- 学业成绩是通过9年级的平均成绩来衡量的.
- 对AR的影响与没有AR的兄弟姐妹进行了比较;根据使用情况分析了药物效应.
主要成果:
- 没有观察到AR对教育成果的显著影响.
- 增加抗AR药物的使用与更高的平均成绩相关.
- 对过敏原免疫疗法 (AIT) 的启动显示,与不服用药物相比,测试得分增加了0.60分.
结论:
- 过敏性鼻炎 (AR) 本身似乎不会影响丹麦人口的教育成果.
- 使用缓解AR的药物与更好的教育成果有关.
相关概念视频
Allergic Reactions
27.2K
Overview
27.2K
Attention-Deficit/Hyperactivity Disorder
36
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
36
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma: Pathogenesis and Management
346
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
346
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
236
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
236


